Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Vertebral Compression Fracture Devices Market size was valued at USD 1.7 billion in 2024 and is expected to reach USD 3.5 billion by the end of 2037, registering at a CAGR of 6.4% during the forecast period, i.e., 2025 to 2037. In 2025, the industry size of vertebral compression fracture devices is assessed at USD 1.8 billion.
The market is highly driven by a surge in the patient pool based on the need for interventions, which is effectively expanding owing to the rising occurrence of osteoporosis and an increase in the aging population. As stated in the 2023 World Health Organization (WHO) report, an estimated 9.1 million osteoporotic-specific fractures occur every year, out of which 28% to 37% of overall cases are attributed to the incidence of vertebral fractures. This has resulted in the growing need for different vertebral compression fracture (VCF) devices such as spinal braces, vertebroplasty kits, and balloon kyphoplasty systems, thereby driving the market development globally.
Furthermore, the component of the medical device supply chain for VCF diagnosis is yet another factor amplifying the market internationally. This includes the distribution of special materials, including biocompatible polymers, titanium alloys, and polymethylmethacrylate (PMMA) bone cement. Besides, according to the U.S. Bureau of Labor Statistics (BLS) report, the producer price index for surgical supplies and appliances has surged by 3.3% due to a rise in the price strategy. Likewise, the consumer price index for medical appliances and equipment rose by 4.2% due to an increase in end-user pricing, thus creating a prolific opportunity for the market upliftment.
Vertebral Compression Fracture Devices Sector: Growth Drivers and Challenges
Growth Drivers
- Government reimbursement and spending policies: The presence of administrative health and medical programs denotes a positive influence on the vertebral compression fracture devices market globally. For instance, the Medicare expenditure in the U.S. for spinal fracture ailment increased by 7.1% every year since 2020, and reached USD 1.9 billion in 2023. Meanwhile, in Europe, the public insurance provision of €320.5 million in Germany for spinal fracture care enhanced to USD 121.9 billion in 2023. Besides, the U.S. FDA approval for cutting-edge VCF devices and systems has also contributed to market development.
- Improvement in health quality: This is yet another factor, which is positively driving the market across different nations. For instance, clinical studies conducted by the AHRQ mostly emphasized on affordable VCF management to reduce treatment cost by 21% with the implementation of bundled payment models. Besides this, there has been an allocation of USD 50.5 million for care programs pertaining to osteoporosis in 2024. Also, the Hospital Readmissions Reduction Program (HRRP) of Medicare punishes infrastructures with vigorous VCF re-admissions that accelerate the best guideline adoption.
Key Manufacturer Strategies Shaping the Market
The vertebral compression fracture devices market is fueled by suitable and standard strategies such as regulatory advancements, acquisitions, and product innovation. Leading organizations and manufacturers are implementing minimally invasive technologies and catering to rapid regulatory approvals to gain increased revenue. For instance, according to the 2023 U.S. FDA report, Medtronic’s Kyphon balloon kyphoplasty systems achieved a cumulative USD 320.5 million in revenue in 2023, owing to an expansion in the Medicare coverage policy. Likewise, Tritanium implants, launched by Stryker Corporation, also gained a revenue of USD 290.5 million in 2023 based on the similar reason, thus positively impacting the overall market.
VCF Device Manufacturers' Revenue Growth Opportunities
|
Company |
Strategy |
Revenue Impact (USD Million) |
Market Share Change |
|
Medtronic |
Kyphon kyphoplasty expansion |
320.5 (2023) |
+8.2% |
|
Stryker Corporation |
Tritanium implant launch |
290.5 (2023) |
+12.1% |
|
Johnson & Johnson |
Cementless VCF devices in Europe |
180.6 (2023) |
+5.2% |
|
Siemens Healthineers |
AI surgical navigation adoption |
95.8 (2023) |
+4.5% |
Key Feasibility Models for Market Expansion
The vertebral compression fracture devices market is continuously undergoing transformative development owing to value-based care models, local manufacturing processes, and tactical partnerships. For instance, VCF suppliers in India entered into a partnership with local hospital facilities and successfully diminished costs by approximately 25.5%. Besides, emerging countries are readily implementing localized assembly centers, and with this method, Brazil reduced its import costs by 30.7% through regional production procedures. Therefore, the presence of all these models is sustainable in nature and effectively caters to overcoming barriers, thereby bolstering the market expansion.
Feasibility Models for VCF Market Expansion
|
Region |
Model |
Outcome |
Revenue Impact |
|
India |
Hospital partnerships |
12.2% adoption increase (2022-2024) |
+USD 45.8 million |
|
Germany |
Bundled payments |
18.5% reimbursement growth (2023) |
+ USD 90.4 million |
|
USA |
Medicare CJR model |
USD 1,200.5 cost reduction per procedure |
+ USD 220.6 million |
|
Brazil |
Localized manufacturing |
30.3% lower import costs (2024) |
+USD 60.6 million |
Challenges
- Strict regulatory processes: This factor poses a huge challenge for the vertebral compression fracture devices market's upliftment in every country. This readily affects manufacturers since they have to undergo complicated administrative pathways, ultimately resulting in delayed market entry. For instance, the typical review time of the U.S. FDA for Class III VCF devices upsurged to 19 months in 2023. Likewise, the presence of the UE MDR requirements in Europe offered an additional 7 to 10 months of acceptance timelines, which led to a 16% drop in the submission of the latest device, thus causing a hindrance in the market growth.
- Limitation in insurance coverage: This is another challenge that negatively impacts the market across nations. For instance, only 62.5% of the U.S. Medicaid programs take into consideration kyphoplasty, which in turn, excludes accessibility for 39% of low-income patients. Insurers in Germany rejected 23% of overall procedural claims in 2023 owing to the existence of stringent medical regulations and rules. However, to combat this, Johnson & Johnson implemented certain effective contracts, resulting in 25.8% fewer readmissions, denoting a flourishing market opportunity.
Vertebral Compression Fracture Devices Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.4% |
|
Base Year Market Size (2024) |
USD 1.7 billion |
|
Forecast Year Market Size (2037) |
USD 3.5 billion |
|
Regional Scope |
|
Vertebral Compression Fracture Devices Segmentation
Age Group (65+ Years, <65 Years)
Based on age group, the 65+ years segment is projected to account for the highest share of 72.9% in the vertebral compression fracture devices market during the forecast timeline. The segment’s growth is highly attributed to the existence of age-specific bone degradation, which positively impacts the overall market development and expansion. For instance, according to the 2024 CDC report, 1 in every 5 seniors in the U.S. is expected to experience vertebral fractures, which includes an accelerated USD 5.3 billion in treatment costs by the end of 2030. Besides, the bioactive cement implementation aims to diminish complexes by 40.6% for the elderly population, thus driving the segment’s upliftment.
End User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics)
Based on end user, the hospitals segment is estimated to hold the second-largest share of 65.5% in the vertebral compression fracture devices market by the end of 2037. This segment readily serves as the ultimate setting for complicated spinal interventions, which effectively amplifies the market demand globally. As stated in the 2024 CMS report, more than 85.8% of the total inpatient kyphoplasty processes are conducted in hospital environments owing to the need for progressive post-operational monitoring devices and imaging systems. Also, the Hospital Association in America reported the establishment of steadfast spine facilities across 73% of Level I trauma hubs, with a yearly procedural volume increasing by more than 520 VCF cases.
Procedure (Minimally Invasive Surgery (MIS), Open Surgery)
Based on the procedure, the minimally invasive surgery (MIS) is anticipated to acquire a share of 58.7% in the vertebral compression fracture devices market during the forecast period, effectively facilitated by cost-efficiency and heightened clinical results. According to a report published by NIH in 2024, in 2023, the U.S. FDA’s clearances of 15 next-generation MIS systems and devices, such as robot-based platforms, have increased the adoption, wherein almost 72.5% of the overall U.S. hospitals provide these standard procedures. Also, the 2024 CMS data report revealed that the cost of MIS procedures is USD 8,250, which is less per case in comparison to open surgeries.
Our in-depth analysis of the global market includes the following segments:
|
Age Group |
|
|
End User |
|
|
Procedure |
|
|
Product Type |
|
|
Material |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Vertebral Compression Fracture Devices Industry - Regional Synopsis
North America Market Analysis
North America is anticipated to hold the highest share of 39.8% in the vertebral compression fracture devices market by the end of 2037. This regional growth is highly driven by the presence and availability of increased prevalence of different types of fractures and robust medical and healthcare infrastructures. Countries such as the U.S. are projected to record almost 85.4% of the overall regional revenue, and Canada effectively contributes an estimated USD 151.9 billion in yearly spending, especially for VCF systems such as kyphoplasty, thus suitable for market expansion.
The market in the U.S. is significantly undergoing development, fueled by factors such as expansion in Medicare services, increased implementation of innovative technologies, and cost barriers due to high expenditure. For instance, as per the 2024 CMS Government report, the Medicare facility in the country covers almost 92.7% of kyphoplasty procedures. Meanwhile, the presence of the U.S. FDA has resulted in the approval of 15 newest VCF devices that deliberately include AI-based guiding systems. Besides, the out-of-pocket cost for the overall population is USD 2,550 per procedure, all of which positively caters to market growth.
The vertebral compression fracture devices market in Canada is gaining increased traction owing to the existence of components such as provincial disparities, poor accessibility in rural areas, and the presence of localized manufacturing centers. For instance, according to an article published by the CIHI in 2024, Ontario comprises approximately 90.5% of the overall vertebral procedures in comparison to 60.7% in the Atlantic region of the country. Besides, almost 40.5% of the total population are required to travel for more than 100 km to receive treatment, which enhances the market demand. Meanwhile, Teijin Nakashima has acquired the Ontario plant for USD 51 million to reduce import reliance by the end of 2027.
Europe Regional Market Size & Growth
Europe in the vertebral compression fracture devices market is poised to account for a considerable share of 29.3% by the end of the forecast timeline. This regional growth is effectively attributed to the rise in the aging population, as well as the availability of innovative medical and healthcare systems. The Health Data Space initiative of the EU constitutes an investment of €2.7 billion, which is deliberately escalating the AI-specific VCF treatment implementation. Besides, key trends such as stringent EU MDR regulatory policies, cost containment, and the osteoporosis epidemic are efficiently driving the market upliftment in the region.
The market in the UK is gaining increased exposure, attributed to the focus of the NHS on the adoption of minimally invasive spinal intervention. For instance, as per the 2024 NHS England report, there has been an allocation of £1.3 billion, which is approximately 8.1% of the overall specialized budget, for VCF treatment and diagnosis, further reflecting a 25.3% enhancement since 2020. This growth develops from the domestic population, with osteoporosis affecting 3.6 million people, ultimately leading to 500,250 fragility fracture cases every year, thus driving the market need in the country.
There is a huge opportunity for the market in Germany since it comprises the world’s most wide-ranging statutory health insurance system. Besides, in 2023, the Federal Ministry of Health report has displayed the spending of €4.4 billion on VCF treatment, which further covers 95.5% of dedicated procedures through public insurers. Also, the German Medical Association noted that an estimated 68.3% of all hospitals currently utilize AI-based kyphoplasty, which reduces the average procedure timeline to 39 minutes. Meanwhile, the country’s innovative Disease Management Program for Osteoporosis has successfully screened 2.2 million patients, which has enhanced the intervention rate by 27.5%.
Competitive Landscape & Strategic Initiatives
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Organizations in the vertebral compression fracture devices market are continuously and vigorously undertaking initiatives to make their mark and secure their positions in the current market scenario. Zimmer Biomet, Globus Medical, Stryker Corporation, Johnson & Johnson, and Medtronic are the top five companies holding remarkable shares in the market on the basis of their contributions. Strategies such as research and development funding, partnerships based on regulatory policies, expansion of emerging countries, along with mergers and acquisitions, are positively driving the market demand across different nations.
Here is a list of key players operating in the global market:
|
Company Name (Country) |
Market Share |
Key Products/Technologies |
|
Medtronic (Ireland) |
22.2% |
Kyphon balloon kyphoplasty systems |
|
Johnson & Johnson (DePuy Synthes, USA) |
18.3% |
Vertebral augmentation products |
|
Stryker (U.S.) |
15.4% |
Tritanium spinal implants |
|
Globus Medical (U.S.) |
9.4% |
Robot-assisted MIS solutions |
|
Zimmer Biomet (U.S.) |
7.3% |
PMMA bone cement & implants |
|
Siemens Healthineers (Germany) |
xx% |
AI-guided surgical navigation |
|
Smith+Nephew (UK) |
xx% |
Bioactive spinal implants |
|
NuVasive (U.S.) |
xx% |
3D-printed vertebral scaffolds |
|
Orthofix (U.S.) |
xx% |
Non-fusion stabilization devices |
|
B. Braun (Germany) |
xx% |
Cost-effective vertebroplasty kits |
Below are the areas covered for each company under the top 15 global manufacturers:
Recent Developments
- In July 2024, Siemens Healthineers AG declared the U.S. FDA acceptance for its ARTIS icono biplane imaging system, which is suitable for optimizing vertebroplasty and reducing the procedure timeline within 35 minutes.
- In June 2024, Zimmer Biomet Holdings, Inc. entered into a partnership with the Mayo Clinic to launch the Persona osteoporotic spine system, which comprises smart cement that modifies color under optimal viscosity.
- Report ID: 7688
- Published Date: May 20, 2025
- Report Format: PDF, PPT
Have specific data needs or budget constraints?
Reach out to us for a customized quote or to learn more about our special pricing
for startups and universities
Frequently Asked Questions (FAQ)
Vertebral Compression Fracture Devices Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
